Apartment Investment and Management Company 03748R747 US03748R7474 06/10/2026 To conduct an advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 12343703 0 FOR 12343703 FOR Columbus McKinnon Corporation 199333105 US1993331057 08/15/2025 To approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 231732 0 AGAINST 231732 AGAINST Coupang, Inc. 22266T109 US22266T1097 06/11/2026 To consider a non-binding vote to approve the compensation of Coupang, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3602019 0 FOR 3602019 FOR Dnow Inc. 67011P100 US67011P1003 05/20/2026 To consider and act upon an advisory proposal to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1355657 0 FOR 1355657 FOR Franklin Street Properties Corp. 35471R106 US35471R1068 05/14/2026 To approve, by non-binding vote, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1551639 0 AGAINST 1551639 AGAINST Globus Medical, Inc. 379577208 US3795772082 06/03/2026 Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 578177 0 FOR 578177 FOR Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2993510 904405 FOR 2993510 FOR Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2993510 904405 1 YEAR 2993510 FOR John Wiley & Sons, Inc., 968223206 US9682232064 09/25/2025 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1255269 0 FOR 1255269 FOR Keros Therapeutics, Inc. 492327101 US4923271013 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 452277 0 AGAINST 452277 AGAINST Magnera Corporation 55939A107 US55939A1079 03/09/2026 Advisory approval of the Company's named executive officer compensation for the fiscal year ended September 27, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 1780649 0 FOR 1780649 FOR Markel Group Inc. 570535104 US5705351048 05/20/2026 Advisory vote on approval of executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 81309 0 FOR 81309 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 142623 0 FOR 142623 FOR Ovid Therapeutics Inc. 690469101 US6904691010 07/09/2025 Advisory approval of the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2461921 0 FOR 2461921 FOR PAR Technology Corporation 698884103 US6988841036 05/29/2026 Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers ("Say-on-Pay Vote"). SECTION 14A SAY-ON-PAY VOTES ISSUER 28949 0 FOR 28949 FOR Primo Brands Corporation 741623102 US7416231022 04/28/2026 Advisory Vote to Approve Executive Compensation. Approval, on an advisory (non-binding) basis, of the compensation of Primo Brands Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1321942 0 FOR 1321942 FOR Sandisk Corporation 80004C200 US80004C2008 11/18/2025 Approval on an advisory basis of the named executive officer compensation disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2539403 0 FOR 2539403 FOR Sandisk Corporation 80004C200 US80004C2008 11/18/2025 Approval on an advisory basis of the frequency of future advisory votes on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2539403 0 1 YEAR 2539403 FOR Sinclair, Inc. 829242106 US8292421067 06/04/2026 Approval, by non-binding advisory vote, on our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 917341 0 FOR 917341 FOR Solventum Corporation 83444M101 US83444M1018 05/15/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 1107206 103837 FOR 1107206 FOR STAAR Surgical Company 852312305 US8523123052 06/18/2026 Approve on a non-binding advisory basis the compensation of the Company's named executive officers ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1569678 0 FOR 1569678 FOR Stagwell Inc. 85256A109 US85256A1097 06/11/2026 Approval, on an advisory basis, of the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3276688 0 FOR 3276688 FOR Theravance Biopharma, Inc. G8807B106 KYG8807B1068 06/12/2026 Approve the non-binding advisory resolution regarding the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8944605 0 FOR 8944605 FOR Turning Point Brands, Inc. 90041L105 US90041L1052 05/04/2026 To approve, on an advisory basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 247723 0 FOR 247723 FOR UniFirst Corporation 904708104 US9047081040 12/15/2025 The Company's proposal to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as more fully described in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1 0 AGAINST 1 NONE